Clotting
Showing 1 - 25 of 1,736
Extracorporeal Circulation Trial in Thessaloniki (Activated Clotting Time measurements combined with heparin concentration
Completed
- Extracorporeal Circulation
- Activated Clotting Time measurements combined with heparin concentration monitoring
- Activated Clotting Time
-
Thessaloniki, GreeceAHEPA University Hospital, Aristotle University of Thessaloniki
Jul 12, 2023
Hemodialysis Complication, Anticoagulants Trial (anticoagulation dosing)
Not yet recruiting
- Hemodialysis Complication
- Anticoagulants
- anticoagulation dosing
- (no location specified)
Nov 17, 2023
Surgery, Cardiac, Tranxemic Acid, Activated Clotting Time Trial (Tranexamic acid)
Not yet recruiting
- Surgery, Cardiac
- +4 more
- Tranexamic acid
- (no location specified)
Oct 30, 2023
Emicizumab on Activated Clotting Time Using i-STAT Alinity
Not yet recruiting
- Hemophilia A
- ACT
- (no location specified)
May 9, 2023
Bleeding, Coagulation Trial in Gent (Amount of anticoagulant Clexane)
Not yet recruiting
- Bleeding
- Coagulation
- Amount of anticoagulant Clexane
-
Gent, BelgiumGhent University Hospital
Aug 8, 2022
Clotting Parameters After Medical Abortion
Completed
- Abortion Early
- +7 more
- Thromboelastometry
- +4 more
-
Edinburgh, United KingdomChalmers Centre for Sexual and Reproductive Health
Apr 19, 2022
Risk of Bleeding Whilst Physical Active Conditions
Recruiting
- Hemophilia A
- Observation of the association between clotting factor level and risk of bleeding whilst physical activity
-
Wuppertal, North Rhine-Westphalia, GermanyDepartment of Sports Medicine, University of Wuppertal
May 17, 2022
Inflammation, Blood Clotting and Blood Vessel Function in
Enrolling by invitation
- Inflammation
- Pathologic Processes
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Inflammation and Clotting Abnormalities in Aneurysmal Coronary
Recruiting
- Coronary Artery Aneurysm
- +2 more
- Evaluation of inflammation and clotting
-
Krakow, PolandDepartment of Cardiac and Vascular Diseases, John Paul II Hospit
Jan 6, 2022
Patients Undergoing Coronary Angiography and Percutaneous
Not yet recruiting
- Chronic Coronary Insufficiency
- Smoking
- (no location specified)
Apr 13, 2022
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in United States (coagulation factor VIIa [recombinant]-jncw)
Recruiting
- Hemophilia A With Inhibitor
- Hemophilia B With Inhibitor
- coagulation factor VIIa [recombinant]-jncw
-
Phoenix, Arizona
- +23 more
Aug 10, 2022
Transgenderism, Clotting Disorder Trial in Milwaukee (Estradiol Tablets, Transdermal patch)
Terminated
- Transgenderism
- Clotting Disorder
- Estradiol Tablets
- Transdermal patch
-
Milwaukee, WisconsinFroedtert Hospital
Dec 19, 2022
Hemophilia, Embolization, Hemarthrosis Trial in São Paulo (embolization with spherical microparticles embosphere)
Recruiting
- Hemophilia
- +5 more
- embolization with spherical microparticles embosphere
-
São Paulo, BrazilInstituto de Ortopedia e Traumatologia do Hospital das Clinicas
Nov 16, 2022
Extended Half-Life Clotting Factor for Improving Musculoskeletal
Recruiting
- Haemophilia
- EHL clotting factor
-
Madrid, Comunity Of Madrid, SpainUniversidad Europea de Madrid
Sep 1, 2021
Hemophilia A Trial (Fitusiran (SAR439774), Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin
Not yet recruiting
- Hemophilia A
- Fitusiran (SAR439774)
- +3 more
- (no location specified)
Nov 17, 2023
Hemodialysis, Coagulation Trial in Gent (Dialyzer type, Dialysis duration)
Completed
- Hemodialysis
- Coagulation
- Dialyzer type
- Dialysis duration
-
Gent, BelgiumGhent University Hospital - Nephrology
Aug 9, 2021
Cholecystitis/Cholelithiasis Trial in Seoul (Laparoscopic cholecystectomy)
Not yet recruiting
- Cholecystitis/Cholelithiasis
- Laparoscopic cholecystectomy
-
Seoul, Seocho-gu, Banopo-dong, Korea, Republic ofDepartment of HBP Surgery, Seoul St. Mary's hospital
Feb 1, 2023
ATHN 8: Previously Untreated Patients (PUPs) Matter Study
Completed
- Hemophilia
- +7 more
-
Phoenix, Arizona
- +26 more
Jan 30, 2023
Drug Toxicity, Platelet Dysfunction, Clotting Disorder Trial in Graz (Tramadol)
Recruiting
- Drug Toxicity
- +2 more
-
Graz, AustriaDept. of Anaesthesiology and Intensive Care Medicine, Medical Un
Jul 26, 2022
SARS-COV2 Infection, COVID-19 Disease, Hospitalized Patients Trial in Ioánnina (low molecular weight Heparin as standard of care
Completed
- SARS-COV2 Infection
- +2 more
- low molecular weight Heparin as standard of care treatment
-
Ioánnina, Epirus, GreeceUniversity General Hospital of Ioannina
Sep 27, 2021
Clotting Disorder Trial (Reinforcement Learning, Heath Care Provider)
Withdrawn
- Clotting Disorder
- Reinforcement Learning
- Heath Care Provider
- (no location specified)
Feb 17, 2022
Clotting Factor VIII and Bleeding Adverse Reactions in Patients
Withdrawn
- Bleeding
- Ischemic Stroke
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Mar 22, 2022
ATHN 9: Severe VWD Natural History Study
Recruiting
- Von Willebrand Diseases
-
Orange, California
- +20 more
Feb 16, 2022
Transcatheter Aortic Valve Replacement, Percutaneous Coronary Intervention Trial in Rotterdam (activated partial thrombin time)
Recruiting
- Transcatheter Aortic Valve Replacement
- Percutaneous Coronary Intervention
- activated partial thrombin time
-
Rotterdam, Zuid Holland, NetherlandsErasmus University Medical Center
Jul 25, 2022